logo

CSBR

Champions Oncology·NASDAQ
--
--(--)
--
--(--)
3.59 / 10
Netural

Capital flow is robust with a fund flow score of 7.18/10, indicating strong inflow momentum. Small-cap trends are positive, while larger block flows are negative, hinting at short-term buying pressure offset by institutional selling. Analyst sentiment is overwhelmingly bullish with a 100% Strong Buy rating from one analyst, yet the historical win rate is 0%, underscoring skepticism. The combination of positive fund flow and bullish analyst stance contrasts with weak technicals and a neutral overall score.

FundamentalSentiment(3.59)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

100%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2025-03-12
InstitutionCraig-Hallum
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for CSBR?
  • CSBR holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.59/10 (Netural).